Fox Corp Class A vs Relay Therapeutics Inc. Common Stock — how do they compare? Fox Corp Class A trades at $62.41 (market cap $25.36B), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: Fox Corp Class A is far larger — about 6.6× Relay Therapeutics Inc. Common Stock's market cap, and Fox Corp Class A pays a 0.91% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fox Corp Class A for 34 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| FOXA | RLAY | |
|---|---|---|
Market Cap | $25.36B | $3.82B |
Volume | 2,566,954 | 4,332,079 |
Sector | Media | Health |
52-Week High | $76.11 | $20.75 |
52-Week Low | $48.79 | $6.03 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $28.72B | $2.93B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Fox Corporation (FOXA) trades at $63.57, up 1.39% today, with a bullish technical signal and strong fundamental performance. Recent quarters show consistent earnings beats, with Q2 2026 EPS of $1.79 exceeding the $1.44 estimate. The company's 2025 revenue grew to $16.3 billion, with a net income margin of 13.88%, while analyst consensus is bullish with a $72 price target. Key developments include the pending $22 billion Roku acquisition, currently under DOJ review, and insider buying by CEO Lachlan Murdoch.
The outlook for FOXA is positive, supported by earnings momentum, reasonable valuation (P/E 16.55), and strategic acquisitions. However, risks include regulatory scrutiny of the Roku deal and potential integration challenges. The stock offers upside to the consensus target but faces headline volatility from merger progress.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →